Cardiac Implants and
Monitoring Devices are used for not only improving the lifestyle but also
extending the lifespan of millions of people worldwide. By engineering
modifications, the latest changes in the last 40 years have revolutionized the
treatment of cardiac diseases. Cardiac Implants and Monitoring Devices have
drastically improved early diagnosis, treatment and epidemiology of various
heart diseases and congenital heart ailments.
Cardiac disease is a group
of disorders of blood vessels and heart. Congenital heart defects, coronary
artery disease and heart rhythm problems are some of the major cardiac
diseases. Most common cause of heart disease is narrowing or blockage of blood
vessels and coronary artery i.e. ischemic heart disease. Cardiac disease is
mainly caused due to high cholesterol, smoking and high blood pressure. In
addition, several other diseases such as, diabetes and obesity, and lifestyle
changes such as poor nutrition, excessive alcohol and physical inactivity
causes higher risk of cardiac diseases. In the U.S., heart disease is the
leading cause of death in men and women. Thus this region becomes a strong
market area for the Cardiac Implant Devices Market.
Table
of contents and insights:
http://industryarc.com/Report/2332/Cardiac-Implants-Devices-Market-Analysis-Report.html
http://industryarc.com/Report/2332/Cardiac-Implants-Devices-Market-Analysis-Report.html
Market
Trends & Growth:
According
to IndustryARC, the Cardiac Implants Devices Market will grow significantly in
the coming 5 years and projected to reach $43.4 Billion by 2020 rising at a
CAGR of 12.5%. Considering the market being $21.4 Billion
in 2014, the current growth estimation seems hopeful for the investors.
Advancement in technology,
growing incidences of cardiovascular diseases such as coronary artery diseases
(CAD), atrial fibrillation and aortic aneurysms and launch of new and
innovative cardiac products such as leadless pacemakers, subcutaneous defibrillators
(S-ICDs) are some of the Key Drivers
for the growth of this market.
Segment
wise, coronary stents devices are generating the largest revenue whereas in
future TAVR (Transcatheter Aortic Valve Replacement) valves are expected to
capture the major market segment.
Regionally, Americas and Europe were noted to have occupied a substantial
market share of 60% and 22% respectively. It can be observed that
Asia-Pacific is growing higher rate as compared to developed countries but
generating lesser revenues due to detrimental factors like cost and
reimbursement policies.
REPORT
SCOPE: Market Segmentation:
The Cardiac Implant Devices
Market is segmented into broad 4 types based on the factors:
- By Devices: Cardiac Resynchronization Therapy Devices (CRT’S), Implantable Cardioverter Defibrillators (ICD’S), Implantable Cardiac Pacemakers (ICPs) and Others.
- By Disease Conditions: Myocardial Ischemia, Acute Myocardial Infarction, Arrhythmias and Others.
- By Procedure: Cardiac Resynchronization Therapy (CRT), Minimally Invasive Heart Surgery and Others.
- By Geography: North America, Europe, APAC and ROW.
Key
Players:
Few notable competitors of
this market which are mentioned in this report are:
- Abbott Vascular Inc.
- Bentley InnoMed GmbH
- Medtronic, Inc.
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Alvimedica
Related Reports You May Be Interested:
Wearable
Medical Devices Market By Type (Therapeutic Wearable Devices, Diagnostic
Devices, Vital Sign Monitoring Devices, Activity Monitors, Electrocardiographs
and Others); By Application (Home Health Care, Remote Patient Monitoring,
Fitness And Sports and Others) and By Geography - Forecast (2015-2020)
http://industryarc.com/Report/205/Wearable-medical-devices-Market-Analysis-Report.html
http://industryarc.com/Report/205/Wearable-medical-devices-Market-Analysis-Report.html
For
More Market Reports:
http://industryarc.com/Domain/8/lifesciences-healthcare-market-research.html
http://industryarc.com/Domain/8/lifesciences-healthcare-market-research.html
For
More Details Contact:
Mr. Sanjay Matthews
Sales Manager
Contact Sales: 1-614-588-8538 (Ext-101)
No comments:
Post a Comment